Bo Li | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Bo Li | Pharmaceutical Science | Best Researcher Award

Researcher at Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China

Dr. Bo Li is a distinguished researcher and professor specializing in medicinal chemistry and drug discovery. He currently serves as a professor and MS supervisor at the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, and the University of Chinese Academy of Sciences. Dr. Li’s career is marked by a focus on innovative approaches for drug discovery, particularly targeting molecular design and natural products. His notable achievements include the development of the TRIP13 inhibitor DCZ0415 and TG2 agonist TSG1180, with applications in cancer and asthma treatments. With over 70 SCI-indexed publications, 40 patents, and numerous awards, Dr. Li has made significant contributions to his field. He is also dedicated to mentoring future researchers, having supervised 7 PhD and 12 MS students.

Professional Profile

Education

Dr. Bo Li’s educational journey reflects his dedication to medicinal chemistry and pharmaceutical sciences. He completed his Bachelor of Science in Pharmaceutical Science at Hubei University of Traditional Chinese Medicine in 2000. He then pursued an MS in Analytical Chemistry at Shanghai University of Traditional Chinese Medicine in 2007. Dr. Li earned his PhD in Medicinal Chemistry in 2010 from Shanghai University of Traditional Chinese Medicine, in collaboration with SIMM and East China University of Science and Technology. Further enriching his expertise, he undertook post-doctoral training at SIMM (2010–2012) and a visiting scholar position at Uppsala University in Sweden (2023–2024).

Professional Experience

Dr. Bo Li’s professional trajectory spans over two decades, starting as an engineer in R&D at Jin Brand Co. Ltd. from 2000 to 2004. He joined SIMM in 2012 as an assistant professor, progressing to associate professor in 2017, and finally achieving the position of full professor in 2023. Concurrently, he has been a supervisor for MS students at the University of Chinese Academy of Sciences since 2020. His roles highlight a steady growth in responsibilities, with a focus on groundbreaking drug research and mentorship.

Research Interest

Dr. Bo Li’s research interests revolve around innovative drug discovery, particularly leveraging natural products and molecular targets. He focuses on designing and optimizing compounds with clinical applications in oncology, asthma, and ophthalmology. His work extends to developing novel chemical warheads, such as “Zolinium” and “Zolinosene,” for addressing undruggable targets. Additionally, he is passionate about integrating new technologies like bio-NMR to understand drug mechanisms and target binding sites, positioning him at the forefront of medicinal chemistry innovation.

Research Skills

Dr. Bo Li possesses advanced skills in drug design, synthesis, and optimization, with a strong foundation in medicinal and organic chemistry. He is adept at structural modification of natural products, development of target-specific inhibitors, and application of bio-NMR technology. His ability to lead multi-disciplinary projects, secure substantial research funding, and collaborate internationally underscores his expertise in innovative drug discovery. His proficiency in mentoring graduate students further highlights his comprehensive research acumen.

Awards and Honors

Dr. Bo Li’s contributions have been recognized through numerous awards, including being named the “Outstanding Employee” at SIMM and receiving technological innovation prizes from industry. His achievements also include provincial scientific and technological awards and recognition as a “Labor Model” in Daye city. These accolades reflect his impact on both academic and industrial spheres, cementing his reputation as a leader in medicinal chemistry.

Conclusion

Dr. Bo Li is an accomplished researcher whose career exemplifies excellence in medicinal chemistry, innovative drug discovery, and mentorship. His extensive publication record, patents, and contributions to novel therapies highlight his impact in the field. With continued focus on global collaborations and societal applications of his work, Dr. Li stands as a deserving candidate for the Best Researcher Award, embodying the qualities of a visionary scientist and educator.

Publication Top Notes

  1. Title: Development of ketalized unsaturated saccharides as multifunctional cysteine-targeting covalent warheads
    Authors: Dong, S., Huang, H., Li, J., Li, B., Zhu, W.
    Year: 2024
  2. Title: Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma
    Authors: Li, X., Zhang, H., Dong, S., Shi, J., Zhu, W.
    Year: 2024
  3. Title: Corrigendum to “Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells”
    Authors: Feng, Q., Hu, K., Hu, H., Zhu, W., Shi, J.
    Year: 2024
  4. Title: Design, synthesis and structure-activity relationship of 1,8-naphthalimide derivatives as highly potent hCYP1B1 inhibitors
    Authors: Wei, Y., Xiong, Y., Liao, Q., Zhu, W., Ge, G.
    Year: 2024
  5. Title: Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma
    Authors: Chen, G., Gao, X., Jia, X., Zhu, W., Shi, J.
    Year: 2024
    Citations: 6
  6. Title: Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents
    Authors: Wang, J., Zhou, C., Li, B., Zhang, H., Liu, L.
    Year: 2024
  7. Title: Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma
    Authors: Lai, Y., Guo, S., Tang, Q., Zhu, W., Shi, J.
    Year: 2024
  8. Title: A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory
    Authors: Zhang, H., Hu, K., Lu, Y., Zhu, W., Shi, J.
    Year: 2024
  9. Title: Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo
    Authors: Dong, S., Hu, K., Shi, Y., Shi, J., Zhu, W.
    Year: 2024
    Citations: 4
  10. Title: The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
    Authors: Wang, Y., Dong, S., Hu, K., Zhu, W., Shi, J.
    Year: 2023
    Citations: 4

 

Abhishek Jha| Pharmacology | Best Researcher Award

Posted on by ScienceFather

Mr. Abhishek Jha|Pharmacology|Best Researcher Award

Mr. Abhishek Jha, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, India.

Abhishek Jha is a final-year doctoral candidate at the Indian Institute of Technology (BHU), Varanasi, specializing in Pharmaceutical Engineering and Technology. His research focuses on developing nanomedicine-based therapeutic strategies, particularly for breast and lung cancer treatments. Abhishek has hands-on experience with a range of sophisticated instruments, including HPLC, SEM, and fluorescence microscopy, and is proficient in various software used for data analysis and drug formulation. He has contributed to multiple high-impact publications in areas such as targeted drug delivery, nanofiber-based wound healing, and tuberculosis therapy. His projects involve innovative approaches, including redox-responsive nanocarriers and pulmonary nanocrystals, aimed at improving the efficacy and specificity of cancer treatments. With a passion for research and mentoring, Abhishek has guided several undergraduate and postgraduate students. His work, recognized in peer-reviewed journals, reflects his commitment to advancing pharmaceutical sciences, making him a strong contender for research excellence awards.

Profile

Education

Abhishek Jha is a dedicated scholar with a robust educational background in pharmaceutical sciences. He is currently pursuing a Ph.D. in Pharmaceutical Engineering and Technology at the prestigious Indian Institute of Technology (IIT-BHU), Varanasi. His doctoral research, initiated in July 2019, focuses on innovative strategies for nanomedicine-based treatments for breast cancer, with a particular emphasis on tumor-targeted drug delivery systems. Prior to this, Abhishek earned his Master of Pharmacy (M.Pharm) from the same institution in June 2019, specializing in Pharmaceutics. During his postgraduate studies, he achieved an impressive C.G.P.A. of 9.43, showcasing his academic excellence. His foundation in the field was laid during his Bachelor of Pharmacy (B.Pharm) studies at KIET School of Pharmacy, affiliated with AKTU, Ghaziabad, where he graduated with a strong 85.8% in 2017. Abhishek’s education reflects his deep commitment to pharmaceutical research and innovation, laying the groundwork for his promising career in academia and industry.

Professional Experience

Abhishek Jha is a Senior Research Fellow at the Indian Institute of Technology (BHU), Varanasi, where he has been working since July 2019. He is currently pursuing his doctoral degree under the supervision of Prof. Brahmeshwar Mishra, focusing on developing nanomedicine-based strategies for breast cancer therapy. His research includes creating redox-responsive, self-assembled systems for targeted drug delivery and localized breast cancer treatments using dissolving microneedles. Abhishek has extensive experience in the development of nanofibrous matrices for wound healing and tissue regeneration, and has mentored over 20 M. Tech and B. Tech students. Prior to his doctoral research, he worked as a Post-graduate Research Scholar at IIT (BHU) from January 2018 to June 2019, where he gained expertise in fabricating polymeric nanoparticles, micelles, liposomes, and hydrogels, and optimized various disease models for lung and breast cancer, diabetes, and infections in rats, applying QbD approaches for formulation optimization.

Research Interest

Abhishek Jha’s research interests lie at the intersection of pharmaceutical sciences and nanomedicine, focusing on innovative drug delivery systems for targeted cancer therapies. His work emphasizes the development of nanocarriers that enhance the selective accumulation of therapeutics in tumor sites, particularly in the treatment of breast and lung cancers. Jha is particularly skilled in designing redox-responsive self-assembled systems and microneedle technologies to facilitate localized drug delivery. Additionally, he investigates nanofibrous scaffolds with wound healing and anti-infective properties, aiming to improve patient outcomes in chronic diabetic wounds. His extensive experience in formulating various nanomedicines, including polymeric nanoparticles, liposomes, and hydrogels, showcases his commitment to advancing drug delivery approaches. Through his research, Jha aims to contribute significantly to the fields of pharmaceutics and biomedical engineering, ultimately improving therapeutic efficacy and patient care in complex disease management.

Research Skills

Abhishek Jha possesses a robust set of research skills that significantly contribute to his expertise in pharmaceutical engineering and technology. His hands-on experience with sophisticated instruments such as High-Performance Liquid Chromatography, Electron Microscopes, and Atomic Force Microscopes demonstrates his proficiency in advanced analytical techniques. Abhishek’s adeptness in interpreting various spectra for drug characterization, including Differential Scanning Calorimetry and Nuclear Magnetic Resonance spectroscopy, showcases his comprehensive understanding of pharmaceutical formulations. He has successfully developed nanomedicine-based strategies for cancer treatment, exhibiting strong problem-solving skills and innovative thinking. His involvement in mentoring over 20 M. Tech and B. Tech students highlights his leadership abilities and commitment to collaborative research. Additionally, Abhishek’s proficiency in software tools like JMP and Minitab enhances his capacity for data analysis and interpretation. Overall, his combination of technical expertise, mentoring experience, and analytical skills positions him as a valuable asset in the field of pharmaceutical research.

Award and Recognition

Abhishek Jha, a promising final-year doctoral candidate at the Indian Institute of Technology (BHU), Varanasi, has garnered notable recognition for his innovative research in pharmaceutical engineering and drug delivery systems. His work on developing nanomedicine-based strategies for breast cancer treatment has been published in prestigious journals, earning him accolades in the scientific community. Abhishek’s contributions include developing targeted therapies and biomaterials for chronic wound healing, showcasing his commitment to addressing complex medical challenges. He has actively engaged in mentoring over 20 undergraduate and graduate students, reflecting his dedication to fostering the next generation of researchers. His publications in high-impact journals, alongside collaborations with esteemed institutions, further underscore his reputation as a rising star in pharmaceutical sciences. Abhishek’s achievements have not only positioned him as a thought leader in his field but also earned him recognition within academic circles for his innovative approach to drug delivery and cancer therapy.

Conclusion

Abhishek Jha is a highly capable researcher with exceptional skills in nanomedicine and drug delivery systems. His academic excellence, technical proficiency, and extensive publication record position him as a strong contender for the Best Researcher Award. By broadening his research scope and further engaging with industry and public platforms, he could reach new heights in his career, making him a well-deserved candidate for recognition in his field.

Publication Top Notes

  • Electrospun nanofiber-based drug delivery platform: advances in diabetic foot ulcer management
    DR Madhukiran, A Jha, M Kumar, G Ajmal, GV Bonde, B Mishra
    Expert Opinion on Drug Delivery 18 (1), 25-42, 2021.
  • Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy
    M Kumar, A Jha, M Dr, B Mishra
    Expert Opinion on Drug Delivery 17 (10), 1459-1472, 2020.
  • Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis
    DM Pawde, MK Viswanadh, AK Mehata, R Sonkar, S Poddar, AS Burande, …
    Saudi Pharmaceutical Journal 28 (12), 1616-1625, 2020.
  • DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer
    A Jha, MK Viswanadh, AS Burande, AK Mehata, S Poddar, K Yadav, …
    International Journal of Biological Macromolecules 150, 413-425, 2020.
  • Gold liposomes for brain-targeted drug delivery: Formulation and brain distribution kinetics
    R Sonkar, A Jha, MK Viswanadh, AS Burande, DM Pawde, KK Patel, …
    Materials Science and Engineering: C 120, 111652, 2021.
  • Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy
    MK Viswanadh, N Agrawal, S Azad, A Jha, S Poddar, SK Mahto, …
    International Journal of Pharmaceutics 602, 120652, 2021.
  • Formulation and In Vivo Efficacy Study of Cetuximab Decorated Targeted Bioadhesive Nanomedicine for Non-Small-Cell Lung Cancer Therapy
    MK Viswanadh, Vikas, A Jha, SK Reddy Adena, AK Mehata, V Priya, …
    Nanomedicine 15 (24), 2345-2367, 2020.
  • Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation
    A Gupta, S Shetty, S Mutalik, K Nandakumar, EM Mathew, A Jha, B Mishra, …
    Heliyon 9 (10), 2023.
  • Nanocarriers for tuberculosis therapy: design of safe and effective drug delivery strategies to overcome the therapeutic challenges
    K Sarkar, M Kumar, A Jha, K Bharti, M Das, B Mishra
    Journal of Drug Delivery Science and Technology 67, 102850, 2022.
  • Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders
    M Kumar, A Jha, K Bharti, G Parmar, B Mishra
    Nanomedicine 17 (12), 913-934, 2022.
  • Myricetin encapsulated chitosan nanoformulation for management of type 2 diabetes: preparation, optimization, characterization and in vivo activity
    M Upadhyay, RV Hosur, A Jha, K Bharti, PS Mali, AK Jha, B Mishra, …
    Biomaterials Advances 153, 213542, 2023.
  • DNA-Based Nanostructured Platforms as Drug Delivery Systems
    M Kumar, A Jha, B Mishra
    Chem & Bio Engineering 1 (3), 179-198, 2024.
  • Enhanced in vitro therapeutic efficacy of triphenyltin (IV) loaded vitamin E TPGS against breast cancer therapy
    M Singh, NK Rana, MS Muthu, A Jha, TSB Baul, B Koch
    Materials Today Communications 31, 103256, 2022.
  • Biopolymer-based tumor microenvironment-responsive nanomedicine for targeted cancer therapy
    A Jha, M Kumar, K Bharti, M Manjit, B Mishra
    Nanomedicine 19 (7), 633-651, 2024.
  • Fabrication of gelatin coated polycaprolactone nanofiber scaffolds co-loaded with luliconazole and naringenin for treatment of Candida infected diabetic wounds
    M Manjit, K Kumar, M Kumar, A Jha, K Bharti, P Tiwari, R Tilak, V Singh, …
    International Journal of Biological Macromolecules 261, 129621, 2024.
  • Formulation and characterization of polyvinyl alcohol/chitosan composite nanofiber co-loaded with silver nanoparticle & luliconazole encapsulated poly lactic-co-glycolic acid …
    M Manjit, M Kumar, A Jha, K Bharti, K Kumar, P Tiwari, R Tilak, V Singh, …
    International Journal of Biological Macromolecules 258, 128978, 2024.
  • Marine biopolymers for transdermal drug delivery
    M Kumar, A Jha, B Mishra
    Marine Biomaterials: Drug Delivery and Therapeutic Applications, 157-207, 2022.
  • Marine Biopolymer-Based Anticancer Drug Delivery Systems
    A Jha, M Kumar, B Mishra
    Marine Biomaterials: Drug Delivery and Therapeutic Applications, 351-401, 2022.
  • Metronidazole Loaded Polycaprolactone-Carbopol Blends Based Biodegradable Intrapocket Dental Film for Local Treatment of Periodontitis
    N Dhedage, G Khan, G Ajmal, M Kumar, A Jha, B Mishra
    Drug Delivery Letters 11 (1), 34-43, 2021.
  • Lipid-coated nanocrystals of paclitaxel as dry powder for inhalation: Characterization, in-vitro performance, and pharmacokinetic assessment
    M Kumar, A Jha, K Bharti, M Manjit, P Kumbhar, V Dhapte-Pawar, …
    Colloids and Surfaces B: Biointerfaces 237, 113865, 2021.

Tamal Pramanick | Scientific Computing |Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Tamal Pramanick | Scientific Computing |Best Researcher Award

Assist Prof Dr/Tamal Pramanick, National Institute of Technology (NIT) Calicut, India.

Dr. Tamal Pramanick is an Assistant Professor in the Department of Mathematics at NIT Calicut, specializing in numerical methods for partial differential equations, particularly finite element methods. He holds a PhD from IIT Guwahati, where his research focused on the development of two-scale composite finite element methods for parabolic problems in convex and nonconvex polygonal domains. Dr. Pramanick has received several prestigious fellowships, including the NBHM Post-Doctoral Fellowship at IISc Bangalore. His research has been published in numerous SCI-indexed journals, and he has been an invited speaker at international conferences. Dr. Pramanick is actively involved in guiding postgraduate dissertations and organizing academic events such as workshops and webinars. He has also secured research grants for projects on fractional order diffusion equations and nonlinear thermistor equations. His contributions to applied mathematics and his role in fostering academic collaboration make him a distinguished scholar in his field.

Profile

Education

The educational journey began with a Secondary education from the West Bengal Board of Secondary Education in 2006, achieving a percentage of 71.38%. Following that, Higher Secondary education was completed from the West Bengal Council of Higher Secondary Education in 2008, with a percentage of 70.29%. The pursuit of higher education continued with a B.Sc. in Mathematics from the University of Kalyani, West Bengal, from 2008 to 2011, securing a percentage of 70.75%. This was followed by an M.Sc. in Mathematics & Computing from the Indian Institute of Technology (IIT) Guwahati, where the candidate achieved a CPI of 8.23 from 2011 to 2013. The academic path culminated in a Ph.D. from IIT Guwahati, awarded on February 25, 2019, with a CPI of 8.25 for the coursework, focusing on “Two-Scale Composite Finite Element Method for Parabolic Problems in Convex and Nonconvex Polygonal Domains.”

Professional Experience

Dr. Tamal Pramanick is an accomplished Assistant Professor in the Department of Mathematics at NIT Calicut, serving since March 2020. He has a rich background in applied mathematics, with expertise in finite element methods and their applications in solving complex mathematical problems. Dr. Pramanick completed his PhD from the Indian Institute of Technology Guwahati in 2019, focusing on two-scale composite finite element methods for parabolic problems in convex and nonconvex domains. He has held a prestigious post-doctoral fellowship from the National Board of Higher Mathematics (NBHM) at IISc Bangalore. His professional contributions include serving as a reviewer, PhD selection committee member, course coordinator, and departmental seminar coordinator at NIT Calicut. Dr. Pramanick has led several research projects sponsored by national agencies and organized numerous conferences, workshops, and faculty development programs. His work is published in reputed journals, and he regularly delivers invited talks at international conferences and workshops.

Research Interest

Dr. Tamal Pramanick’s research interests lie in the field of applied mathematics, with a focus on numerical methods for solving partial differential equations, particularly the Finite Element Method (FEM) and its applications. His work explores the development and analysis of two-scale composite finite element methods for complex parabolic and elliptic problems in convex and nonconvex polygonal domains. Dr. Pramanick is particularly interested in improving the accuracy and efficiency of numerical solutions for nonlinear and semilinear parabolic equations, with applications spanning diverse fields such as thermistor equations, heat transfer, and diffusion processes. His research also extends to fractional order diffusion equations and mathematical modeling of physical systems. Through his interdisciplinary approach, Dr. Pramanick aims to contribute to advancements in computational mathematics and its practical applications in engineering, physics, and other sciences, making his work highly relevant to both academic research and industrial problem-solving.

Research Skills

Dr. Tamal Pramanick is a proficient researcher specializing in applied mathematics, particularly in the finite element method for complex problems in nonconvex polygonal domains. His expertise spans numerical analysis, mathematical modeling, and the development of error estimates for nonlinear parabolic equations. Dr. Pramanick has demonstrated advanced skills in multi-scale composite finite element methods, with significant contributions to solving fractional-order diffusion equations and semilinear parabolic problems. His research includes high-level computational simulations and analytical techniques for addressing real-world mathematical challenges. He has successfully secured research funding for multiple projects, including Faculty Research Seed Grants and prestigious National Board of Higher Mathematics (NBHM) projects. Additionally, Dr. Pramanick’s experience extends to guiding postgraduate dissertations on topics like heat equations and delay differential equations, while his prolific publications in SCI-indexed journals further attest to his research caliber. His role as an invited speaker and coordinator for various academic events reflects his strong leadership and collaborative research capabilities

Award and Recognition

Dr. Tamal Pramanick, an accomplished Assistant Professor at NIT Calicut, has received multiple awards and recognition for his outstanding contributions to mathematics and computational science. He qualified the prestigious Joint Admission Test for M.Sc. (JAM) in 2011 and the Graduate Aptitude Test in Engineering (GATE) in 2013, both in Mathematics. During his academic journey at IIT Guwahati, he was a recipient of the Merit cum Means Scholarship and awarded Junior and Senior Research Fellowships (JRF and SRF) from 2013 to 2018. In 2019, Dr. Pramanick achieved the National Eligibility Test (NET) for Lectureship and was selected for the National Board of Higher Mathematics (NBHM) Postdoctoral Fellowship. His innovative research has earned him prestigious grants, including a Faculty Research Seed Grant and NBHM-funded projects, advancing his work in finite element methods and nonlinear equations. His invited talks at international conferences further highlight his scholarly impact on the global stage.

Conclusion

 Dr. Tamal Pramanick is a highly qualified candidate with a solid track record of research, teaching, and leadership. His achievements in securing grants, organizing academic programs, and contributing to mathematical research through high-impact publications position him as a strong contender for the Best Researcher Award. With minor improvements in international collaboration and interdisciplinary research, his candidacy would be even stronger.

Publication Top Notes

  • Error estimates for two-scale composite finite element approximations of parabolic equations with measure data in time for convex and nonconvex polygonal domains

Authors: T. Pramanick, R.K. Sinha

Citation: Applied Numerical Mathematics, 143, 112-132

Year: 2019

  • Two-scale composite finite element method for parabolic problems with smooth and nonsmooth initial data

Authors: T. Pramanick, R.K. Sinha

Citation: Journal of Applied Mathematics and Computing, 58, 469-501

Year: 2018

  • A hybrid high-order method for quasilinear elliptic problems of nonmonotone type

Authors: T. Gudi, G. Mallik, T. Pramanick

Citation: SIAM Journal on Numerical Analysis, 60(4), 2318-2344

Year: 2022

  • Composite Finite Element Approximation for Parabolic Problems in Nonconvex Polygonal Domains

Authors: T. Pramanick, R.K. Sinha

Citation: Computational Methods in Applied Mathematics, 20(2), 361-378

Year: 2020

  • Composite finite element approximation for nonlinear parabolic problems in nonconvex polygonal domains

Authors: T. Pramanick, R.K. Sinha

Citation: Numerical Methods for Partial Differential Equations, 34(6), 2316-2335

Year: 2018

  • Adaptation of the composite finite element framework for semilinear parabolic problems

Authors: A. Anand, T. Pramanick

Citation: Journal of Numerical Analysis and Approximation Theory, 53(1), 26-53

Year: 2024

  • Error estimates for finite element approximations of nonlinear parabolic problems in nonconvex polygonal domains

Authors: T. Pramanick, S. Mahata, R.K. Sinha

Citation: Advances in Mathematics: Scientific Journal, 9(9), 6513-6524

Year: 2020

  • Two scale composite finite element method for parabolic problems in convex and nonconvex polygonal domains

Authors: T. Pramanick

Citation: Guwahati

Year: 2019

  • Managing error estimates for semidiscrete finite element approximations of semilinear parabolic equations in a nonconvex polygon

Authors: T. Pramanick

Year: 2018

  • Adaptation of a variant of finite element method for the evolution equation in nonconvex domain

Authors: A. Anand, T. Pramanick

Event: 2025 Joint Mathematics Meetings (JMM 2025)

  • Composite finite element method implementation for nonlinear parabolic problems in nonconvex domains

Authors: T. Pramanick, R.K. Sinha

Year: Not specified in your list

  • Fully discrete finite element approximations of semilinear parabolic equations in a nonconvex polygon

Authors: T. Pramanick, R.K. Sinha

Year: Not specified in your list

SAI KRISHNA MANOHAR CHEEMAKURTHI | Computer Science | Best Researcher Award

Posted on by ScienceFather

Mr. Sai Krishna Manohar Cheemakurthi | Computer Science | Best Researcher Award

Sai Krishna Manohar Cheemakurthi, U.S. BANK, United States.

Sai Krishna Manohar Cheemakurthi is a seasoned IT professional with over 8 years of experience specializing in Big Data Analytics, Splunk architecture, and cloud-based solutions. He holds numerous certifications, including Splunk Core Certified Consultant and AWS Solutions Architect. Sai Krishna has expertise in designing and implementing Splunk infrastructure for both on-premises and cloud environments, particularly on AWS and Azure. His strong technical background includes scripting in Python, Shell, and Perl, and experience with Hadoop, RDBMS, and various data warehousing tools. Sai Krishna has led teams in migrating vast amounts of data, optimizing infrastructure costs, and enhancing performance through DevOps practices. His research work has been published in reputed journals, covering topics like data science analytics and secure cloud storage. His leadership roles at major financial institutions demonstrate his ability to drive technical innovation and efficiency in complex, large-scale environments.

Profile:

Education

Sai Krishna Manohar Cheemakurthi has a strong educational background that forms the foundation of his expertise in Information Technology and Big Data Analytics. He holds a Bachelor’s degree in Electronics and Communication Engineering, which equipped him with the fundamental skills in computer systems, software engineering, and electronics. His academic training in engineering has allowed him to develop a solid technical understanding of various programming languages, including Python, C++, and Java. Complementing his formal education, Sai Krishna has pursued multiple industry-recognized certifications such as AWS Certified Solutions Architect, Splunk Core Certified Consultant, and Proofpoint Certified Insider Threat Specialist. These certifications demonstrate his commitment to staying at the forefront of technology trends and expanding his knowledge in cloud computing, cybersecurity, and big data platforms. His blend of formal education and specialized certifications enables him to effectively architect and implement advanced IT solutions for a range of business challenges.

Professional Experiences 

Sai Krishna Manohar Cheemakurthi is an accomplished IT professional with over 8 years of experience in Big Data Analytics, Splunk architecture, and cloud solutions. Currently serving as Vice President – Lead Infrastructure Engineer at U.S. Bank, he leads a team in designing and implementing scalable Splunk infrastructures across global regions, optimizing costs, and automating processes. Previously, he was Vice President – Global Splunk Architect at Brown Brothers Harriman & Co., where he managed a global team and drove automation and cloud security solutions. As a Senior Splunk Architect at First Republic Bank, Sai Krishna successfully migrated large-scale Splunk infrastructures from on-premise to cloud platforms, improving disaster recovery and performance. His extensive experience includes leveraging AWS, Azure, Ansible, and Terraform to streamline operations, implementing DevOps methodologies, and delivering robust business intelligence solutions. Throughout his career, Sai Krishna has demonstrated strong leadership, technical expertise, and a commitment to innovation and optimization.

Awards and Honors

Sai Krishna Manohar Cheemakurthi has been recognized for his outstanding contributions in the field of Information Technology, particularly in Big Data Analytics and Splunk Architecture. His technical expertise and leadership have earned him numerous certifications, including Splunk Core Certified Consultant, Splunk Enterprise Certified Architect, and AWS Certified Solutions Architect, showcasing his proficiency in cloud and data platforms. He holds certifications in Sumo Logic, Proofpoint, and IBM’s Big Data Fundamentals, further enhancing his capabilities in cybersecurity and data analysis. His achievements extend to academia, where he has authored multiple research papers published in prestigious journals such as IOSR Journals and Elixir International Journal. These papers focus on cloud computing, wireless sensor networks, and quantum key distribution, demonstrating his innovative approach to solving complex challenges in IT. Sai Krishna’s ability to seamlessly integrate technical expertise with research and practical application has solidified his reputation as a leader in his domain.

Research Interest

Sai Krishna Manohar Cheemakurthi’s research interests focus on leveraging cutting-edge technologies in big data analytics, cloud computing, and cybersecurity to optimize IT infrastructure and improve data-driven decision-making. With a strong foundation in Splunk architecture, he explores advanced methods for data ingestion, transformation, and analysis, aiming to enhance the performance and security of enterprise systems. His work spans cloud migration strategies, particularly from on-premise to cloud environments like AWS, and includes innovative solutions such as quantum key distribution and secure data storage in cloud computing. Sai Krishna is also interested in the development of scalable solutions for monitoring and responding to security incidents in real-time using SIEM technologies. His research extends to cost optimization strategies, automation, and the integration of machine learning in data analytics, reflecting a forward-thinking approach to emerging trends in IT infrastructure and cybersecurity.

Research Skills

Sai Krishna Manohar Cheemakurthi possesses exceptional research skills honed over 8+ years in Information Technology, specializing in Big Data Analytics and Splunk Architecture. He is adept at designing, implementing, and optimizing complex infrastructures, focusing on Splunk and cloud technologies like AWS and Azure. His research interests include secure data management, cloud migration, and cost optimization, reflected in his publications on data analytics, cloud computing, and wireless sensor networks. Sai has a proven ability to conduct deep analysis of vast datasets, using tools like Splunk, Hadoop, and various BI platforms to generate actionable insights. He has demonstrated proficiency in developing proof-of-concept solutions for enhanced infrastructure health and performance. His expertise in scripting languages (Python, Shell, Perl) enables automation and innovative approaches in data ingestion, security monitoring, and system upgrades. Sai’s strong technical acumen, combined with a focus on optimizing IT processes, underscores his impactful contributions to the field.

Publication Top Notes
  • Cloud Observability In Finance: Monitoring Strategies For Enhanced Security
    • Authors: NB Kilaru, SKM Cheemakurthi
    • Year: 2023
    • Journal: NVEO-Natural Volatiles & Essential Oils
    • Volume/Issue/Page: 10(1), 220-226
  • Mitigating Threats in Modern Banking: Threat Modeling and Attack Prevention with AI and Machine Learning
    • Authors: SK Manohar, V Gunnam, NB Kilaru
    • Year: 2022
    • Journal: Turkish Journal of Computer and Mathematics Education (TURCOMAT)
  • Next-gen AI and Deep Learning for Proactive Observability and Incident Management
    • Authors: NBK Sai Krishna Manohar Cheemakurthi, Vinodh Gunnam
    • Year: 2022
    • Journal: Turkish Journal of Computer and Mathematics Education
    • Volume/Issue/Page: 13(3), 1550-1564
  • Scaling DevOps with Infrastructure as Code in Multi-Cloud Environments
    • Authors: NBK Sai Krishna Manohar Cheemakurthi, Vinodh Gunnam
    • Year: 2022
    • Journal: Turkish Journal of Computer and Mathematics Education
    • Volume/Issue/Page: 13(3), 1189-1200
  • Advanced Anomaly Detection In Banking: Detecting Emerging Threats Using SIEM
    • Authors: NBK Sai Krishna Manohar Cheemakurthi, Vinodh Gunnam
    • Year: 2021
    • Journal: International Journal of Computer Science and Mechatronics (IJCSM)
    • Volume/Issue/Page: 7(04), 28-33
  • Analytics of Data Science using Big Data
    • Authors: CSK Manohar
    • Year: 2013
    • Journal: IOSR Journal of Computer Engineering
    • Volume/Issue/Page: 10(2), 19-21
  • AI-Powered Fraud Detection: Harnessing Advanced Machine Learning Algorithms for Robust Financial Security
    • Authors: SKM Cheemakurthi, NB Kilaru, V Gunnam
    • Year: (Not provided)
  • Deep Learning Models For Fraud Detection In Modernized Banking Systems: Cloud Computing Paradigm
    • Authors: Y Vasa, SKM Cheemakurthi, NB Kilaru
    • Year: (Not provided)
  • SOAR Solutions in PCI Compliance: Orchestrating Incident Response for Regulatory Security
    • Authors: NB Kilaru, SKM Cheemakurthi, V Gunnam
    • Year: (Not provided)
  • AI-Driven SOAR in Finance: Revolutionizing Incident Response and PCI Data Security with Cloud Innovations
    • Authors: V Gunnam, SKM Cheemakurthi, NB Kilaru
    • Year: (Not provided)

 

 

Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at Arak University of Medical Sciences, Iran. With a Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, her research focuses on the role of microRNAs in cancer diagnosis, treatment, and neurological disorders. Dr. Mondanizadeh has led numerous research projects and thesis works, contributing significantly to the understanding of miRNAs in various diseases, including gastric cancer, glioma, and spinal cord injuries. Her work is widely published in esteemed journals, highlighting her expertise in molecular biology and her commitment to advancing medical science. Dr. Mondanizadeh’s research has practical implications, such as the development of non-invasive diagnostic methods for cancer and the exploration of targeted therapies. Her international exposure, including a visit to the University of Adelaide, further underscores her global perspective and dedication to collaborative research.

Profile
Education

Dr. Mahdieh Mondanizadeh is a highly qualified academic and researcher in the field of molecular medicine. She earned her Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, Hamedan, Iran, where she conducted significant research from 2010 to 2014. Her doctoral thesis focused on evaluating the effect of miR-124 on transcription factors involved in the proliferation and differentiation of neuronal cells. Prior to her Ph.D., Dr. Mondanizadeh completed her M.Sc. in Medical Microbiology at Qom Islamic Azad University, Qom, Iran, from 2005 to 2007, further solidifying her foundation in microbiological research. She also holds a B.Sc. in Microbiology from Arak Azad University, Arak, Iran, which she completed between 2000 and 2004. In 2012, Dr. Mondanizadeh expanded her expertise through a visitorship at the University of Adelaide, Australia, enriching her research experience and international collaboration skills.

Professional Experience

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at the Department of Biotechnology, Arak University of Medical Sciences, Iran. Since joining the institution in 2015, she has made significant contributions to the field of molecular medicine, focusing on the role of microRNAs in cancer diagnosis and treatment. Dr. Mondanizadeh has successfully led numerous research projects, including the development of novel diagnostic assays and the investigation of miRNA-related gene expression in various diseases. Her expertise extends to the study of molecular pathways in cancer, spinal cord injuries, and neurodegenerative diseases. Additionally, she has collaborated with international researchers and published extensively in high-impact journals. Her work is recognized for its innovation and potential to influence future medical treatments, making her a respected figure in the scientific community.

Research Interest

Mahdieh Mondanizadeh’s research interests are deeply rooted in molecular medicine, with a particular focus on the role of microRNAs (miRNAs) in various human diseases. Her work extensively explores the regulatory functions of miRNAs in cancer, neurological disorders, and infectious diseases, aiming to uncover their potential as diagnostic biomarkers and therapeutic targets. Mondanizadeh is especially interested in the molecular mechanisms underlying cancer progression, including the role of miRNAs in signal transduction pathways and gene expression regulation. Her research also extends to the study of miRNA involvement in spinal cord injuries, neurodegenerative diseases, and reproductive health issues. Additionally, she investigates the therapeutic potential of natural compounds and their effects on miRNA expression and cancer treatment. Through her research, Mondanizadeh contributes to the development of novel diagnostic tools and targeted therapies, advancing the field of personalized medicine.

Research Skills

Mahdieh Mondanizadeh is a highly skilled researcher with extensive expertise in molecular medicine and microbiology. Her research skills are demonstrated through her successful management of numerous projects focused on the role of microRNAs in cancer, neurodegenerative diseases, and infectious diseases. She excels in designing and conducting complex experiments, particularly those involving gene expression analysis, miRNA profiling, and the development of diagnostic assays. Her proficiency in molecular techniques such as real-time PCR, immunohistochemistry, and cell culture is complemented by her strong analytical abilities, allowing her to interpret data with precision and contribute to high-impact publications. Additionally, her collaborative approach and leadership in multidisciplinary research projects highlight her ability to integrate various scientific disciplines. Mondanizadeh’s commitment to advancing molecular medicine is further evidenced by her active participation in grant writing and project management, ensuring the successful completion and dissemination of her research findings.

Awards and Recognition

Dr. Mahdieh Mondanizadeh has garnered significant recognition for her impactful contributions to the field of molecular medicine and biotechnology. As an Associate Professor at Arak University of Medical Sciences, she has received multiple research grants and led numerous projects focusing on the role of microRNAs in various diseases, particularly cancer. Her innovative work in non-invasive cancer diagnostics and therapeutic strategies has earned her acclaim both nationally and internationally. Dr. Mondanizadeh has published extensively in high-impact journals, highlighting her research excellence and commitment to advancing medical science. She has also been invited to present her findings at prestigious conferences, further cementing her reputation as a leading researcher in her field. Her dedication to mentoring students and fostering a collaborative research environment has also been recognized, making her a respected figure in the academic community.

Conclusion

Mahdieh Mondanizadeh is a strong candidate for the Best Researcher Award due to her extensive research achievements, leadership in scientific projects, and significant contributions to the understanding of molecular mechanisms in disease. Enhancing the application and impact of her research findings and expanding her international collaborations could further bolster her candidacy. Overall, her work positions her as a deserving contender for this prestigious recognition.

Publications Top Notes

  1. MiRNAs related in signaling pathways of women’s reproductive diseases: an overview
    • Authors: M. Bagheri, B. Khansarinejad, M. Mondanizadeh, M. Azimi, S. Alavi
    • Year: 2024
  2. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells
    • Authors: A. Tafti, S. Shojaei, H. Zali, S. Mohammadi-Yeganeh, M. Mondanizadeh
    • Year: 2023
    • Citations: 2
  3. Assessment of efficacy of carboxytherapy in management of skin aging through evaluation of gene expression profile: a 2-split randomized clinical trial
    • Authors: N. Bagherani, A. Firooz, A. Ghanadan, M. Mondanizadeh, G. Tavoosidana
    • Year: 2023
  4. Hsa-miR-15b-5p/miR-195-5p Controls Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells Through Regulating Indian Hedgehog Expression
    • Authors: S. Harimi, B. Khansarinejad, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  5. Optimizing a Calorimetric Method for Quantitative Assessment of Alkaline Phosphatase to confirm the Osteogenic Differentiation of Mesenchymal Stem Cell
    • Authors: S. Harimi, F. Zare, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  6. The role of microRNAs in diseases and related signaling pathways
    • Authors: A. Vaghf, B. Khansarinejad, E. Ghaznavi-Rad, M. Mondanizadeh
    • Year: 2022
    • Citations: 9
  7. Low Frequency of Adenovirus, Rotavirus, and Norovirus in Pediatric Diarrheal Samples from Central Iran
    • Authors: E. Abbasi, M. Mondanizadeh, A. van Belkum, E. Ghaznavi-Rad
    • Year: 2022
    • Citations: 3
  8. The role of miRNAs as a big master regulator of signaling pathways involved in lymphoblastic leukemia
    • Authors: M. Bagheri, P.Z. Sarabi, M. Mondanizadeh
    • Year: 2022
    • Citations: 3
  9. A Review of the Function of Circulating Cell Free miRNAs as Promising Biomarkers in Cancer Diagnosis, Treatment, and Metastasis
    • Authors: M. Zand, M. Mondanizadeh
    • Year: 2022
  10. Pap Smear miR-92a-5p and miR-155-5p as Potential Diagnostic Biomarkers of Squamous Intraepithelial Cervical Cancer
    • Authors: T. Azimi, M. Paryan, M. Mondanizadeh, H. Sarmadian, A. Zamani
    • Year: 2021
    • Citations: 8